Back to FMR LLC FMR LLC

LXRXLXRX
7 quarters

Position history for FMR LLCFMR LLC's holdings in LEXICON PHARMACEUTICALS INC

FMR LLC holds 51.8M shares of LXRX (LEXICON PHARMACEUTICALS INC), worth $124.3M as of 2026-Q2. The position was increased (+14.9% shares). LXRX represents 0.0% of FMR LLC's portfolio.

Current Value

$124.3M

Current Shares

51.8M

Total Value Change

+$85.9M

Total Shares Change

-188,410

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
51.8M
+14.9%
$124.3M0.0%$2.40
35
2026-Q1
Increased
45.1M
+19.1%
$70.3M0.0%$1.61
35
2025-Q4
Decreased
37.8M
-2.2%
$43.5M0.0%$1.15
0
2025-Q3
Increased
38.7M
+1.4%
$52.2M0.0%$1.39
30
2025-Q2
Increased
38.1M
+10.4%
$36.1M0.0%$0.82
32
2025-Q1
Decreased
34.5M
-33.5%
$15.9M0.0%$0.57
0
2024-Q4
New
52M
-
$38.4M0.0%$0.72
40

Other major holders of LXRX: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, Point72 Asset Management, L.P., UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used